MongoDB (MDB) Stock Forecast & Price Target

Q: What analysts cover MongoDB?

MongoDB has been rated by research analysts at Barclays , BMO Capital Markets , Canaccord Genuity Group , Cantor Fitzgerald , Citigroup , Citizens Jmp , DA Davidson , Evercore , Guggenheim , Mizuho , Monness Crespi & Hardt , Morgan Stanley , Needham & Company LLC , Oppenheimer , Piper Sandler , Robert W. Baird , Rosenblatt Securities , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Stephens , Stifel Nicolaus , The Goldman Sachs Group , Truist Financial , UBS Group , Weiss Ratings , Wells Fargo & Company , William Blair , and Zacks Research in the past 90 days.

$363.03 +2.32 (+0.64%)

Closing price 10/7/2026 04:00 PM Eastern

Extended Trading

$361.74 -1.29 (-0.36%)

As of 09:15 AM Eastern

Compare

MongoDB - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 37 Analyst Ratings

Sell
0

Hold
7

Buy
30

Based on 37 Wall Street analysts who have issued ratings for MongoDB in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 37 analysts, 7 have given a hold rating, 28 have given a buy rating, and 2 have given a strong buy rating for MDB.

Consensus Price Target

$462.59
27.43% Upside

According to the 37 analysts' twelve-month price targets for MongoDB, the average price target is $462.59. The highest price target for MDB is $565.00, while the lowest price target for MDB is $372.00. The average price target represents a forecasted upside of 27.43% from the current price of $363.03.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for MDB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MongoDB and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDB Analyst Ratings Over Time

Type	Current Forecast 10/8/25 to 10/8/26	1 Month Ago 9/8/25 to 9/8/26	3 Months Ago 7/10/25 to 7/10/26	1 Year Ago 10/8/24 to 10/8/25
Strong Buy	2 Strong Buy rating(s)	3 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	28 Buy rating(s)	26 Buy rating(s)	27 Buy rating(s)	27 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)	8 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$462.59	$471.81	$400.41	$342.69
Forecasted Upside	27.43% Upside	32.53% Upside	17.05% Upside	4.87% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

MDB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

MongoDB Stock vs. The Competition

Type	MongoDB	Technology Companies	Broader Market
Consensus Rating Score	2.86	2.24	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	27.43% Upside	623.65% Upside	20.58% Upside
News Sentiment Rating	Neutral News See Recent MDB News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/2/2026	Cantor Fitzgerald 5 of 5 stars	Thomas Blakey 2 of 5 stars	Reiterated Rating	Overweight	$540.00	+53.53%
9/30/2026	DA Davidson 2 of 5 stars	Rudy Kessinger 4 of 5 stars	Lower Target	Buy	$465.00 ➝ $415.00	+17.53%
9/30/2026	Piper Sandler 2 of 5 stars	Rob Owens 1 of 5 stars	Reiterated Rating	Overweight	$470.00	+31.61%
9/30/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$410.00 ➝ $375.00	+11.21%
9/30/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
9/30/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$519.00	+47.84%
9/30/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$465.00	+37.90%
9/30/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$450.00 ➝ $420.00	+24.56%
9/30/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$465.00 ➝ $385.00	+14.18%
9/30/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$398.00 ➝ $372.00	+10.32%
Get the Latest News and Ratings for MDB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MongoDB and its competitors with MarketBeat's FREE daily newsletter.
9/30/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$430.00	+27.52%
9/29/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$460.00	+37.44%
9/29/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$560.00	+67.32%
9/28/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/28/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
9/24/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/3/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
9/2/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell (D-) ➝ Hold (C-)
9/2/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform
9/2/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$460.00 ➝ $500.00	+29.03%
9/2/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Firoz Valliji Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$449.00 ➝ $484.00	+11.47%
9/2/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$400.00 ➝ $480.00	+26.96%
9/2/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$453.00 ➝ $520.00	+36.71%
9/2/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$460.00 ➝ $480.00	+10.55%
9/2/2026	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$395.00 ➝ $445.00	+2.48%
8/25/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacWilliams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$375.00 ➝ $475.00	+17.96%
8/25/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$335.00 ➝ $400.00	-0.67%
8/20/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$400.00 ➝ $475.00	+12.98%
8/12/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$410.00 ➝ $475.00	+8.16%
7/8/2026	KGI Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Outperform	$470.00	+31.81%
6/8/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$390.00 ➝ $450.00	+27.64%
6/2/2026	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$430.00 ➝ $515.00	+30.23%
5/29/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$380.00 ➝ $390.00	+19.75%
12/15/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Cash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Strong-Buy ➝ Market Perform
12/4/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $488.00	+20.29%
12/2/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sector Weight
12/2/2025	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$305.00 ➝ $385.00	-6.23%
8/27/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Zukin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$280.00 ➝ $350.00	+63.29%
5/20/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$350.00 ➝ $190.00	+0.52%
4/17/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$170.00	+6.22%
A dividend every week of the year (Ad) Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering real expenses, that rhythm rarely lines up with the bills. Nathan Slaughter, Chief Investment Strategist at High-Yield Investing, built a full 52-week calendar by sequencing quality dividend payers so every week is covered, including bonus dividends that cluster from December through February. Get instant access to the full dividend calendar now
4/1/2025	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	S. Yoshizu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
1/21/2025	China Renaissance Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Liu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$351.00	+38.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:15 AM ET.

Should I Buy MongoDB Stock? MDB Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 5, 2026. Please send any questions or comments about these MongoDB pros and cons to contact@marketbeat.com.

MongoDB
Bull Case

Here are some ways that investors could benefit from investing in MongoDB, Inc.:

MongoDB, Inc. recently raised its long-term growth targets at its Investor Day, projecting total revenue growth of 20% or more for fiscal years 2028 to 2030, which is an increase from previous high-teens expectations. This upward revision in guidance signals strong confidence in the company's ability to sustain high growth rates, a key driver for long-term shareholder value.
The company demonstrated strong financial performance in its most recent quarter, reporting earnings per share of $1.90, which significantly exceeded the consensus estimate of $1.62. Additionally, revenue reached $771.77 million, surpassing analyst expectations of $735.01 million and representing a 30.5% year-over-year increase, indicating robust demand for its database solutions.
Wall Street analysts maintain a positive outlook on the stock, with a consensus rating of "Moderate Buy" and a consensus price target of $471.81. Recent actions include Cantor Fitzgerald reiterating an "Overweight" rating with a $540.00 price target, suggesting significant potential upside from the current stock price of $359.23.
MongoDB, Inc. has announced a major expansion of its share buyback program, adding $1.35 billion to its authorization. This move signals management's confidence in the company's financial health and its commitment to returning capital to shareholders, which can help support the stock price and reduce the number of shares outstanding.
The company is benefiting from the broader artificial intelligence trend, with its database platform positioned to support AI applications. Bank of America noted that MongoDB has "AI momentum on its side," and the company guides for 25% growth in its Atlas cloud database service over the next three years, highlighting a strong tailwind from AI-driven data storage needs.

MongoDB
Bear Case

Investors should be bearish about investing in MongoDB, Inc. for these reasons:

The stock has experienced significant volatility and a recent decline, trading at $359.23, which is well below its 52-week high of $473.10. The company's price-to-earnings ratio is extremely high at 1556.35, indicating that the stock is priced for near-perfect execution and leaves little room for disappointment in future earnings.
There is uncertainty surrounding company leadership, as recent news reports indicate a CEO search is underway following the departure of the current chief executive. Leadership transitions can create operational disruptions and strategic uncertainty, which may weigh on investor confidence and stock performance in the near term.
Corporate insiders have been consistently selling shares, with Director Dwight A. Merriman and Director Hope F. Cochran executing multiple sales in recent months. For example, Merriman sold 10,000 shares in August 2026 and 6,000 shares in June 2026, while Cochran sold 1,000 shares in September 2026. This pattern of insider selling can be interpreted as a lack of confidence in the stock's near-term upside.
The company's net margin is relatively low at 2.12%, and its return on equity is only 1.06%. These metrics suggest that MongoDB, Inc. is not yet highly profitable on a net basis, which may limit its ability to generate substantial cash flow for dividends or aggressive buybacks without relying on external capital or dilution.
Short interest in the stock remains notable, with 2,879,053 shares shorted as of the most recent record date. While the month-to-month change was a slight decrease of 2.29%, the persistent level of short selling indicates that a segment of the market is betting against the stock's performance, potentially due to valuation concerns or competitive pressures.

MDB Forecast - Frequently Asked Questions

According to the research reports of 37 Wall Street equities research analysts, the average twelve-month stock price forecast for MongoDB is $462.59, with a high forecast of $565.00 and a low forecast of $372.00.

37 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MongoDB in the last year. There are currently 7 hold ratings, 28 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MDB shares.

According to analysts, MongoDB's stock has a predicted upside of 27.43% based on their 12-month stock forecasts.

Over the previous 90 days, MongoDB's stock had 4 upgrades by analysts.

MongoDB has been rated by research analysts at Barclays, BMO Capital Markets, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Citizens Jmp, DA Davidson, Evercore, Guggenheim, Mizuho, Monness Crespi & Hardt, Morgan Stanley, Needham & Company LLC, Oppenheimer, Piper Sandler, Robert W. Baird, Rosenblatt Securities, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, The Goldman Sachs Group, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, William Blair, and Zacks Research in the past 90 days.

Analysts like MongoDB more than other "technology" companies. The consensus rating for MongoDB is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how MDB compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With MongoDB Recommendations

MarketBeat monitors more than a dozen sources for MongoDB analyst ratings, with the most recent rating issued on 10/2/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MongoDB (MDB) Stock Forecast & Price Target